NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

TaiMed Biologics Inc (TWO: 4147)

 
4147 Technical Analysis
5
As on 24th Dec 2025 4147 STOCK Price closed @ 61.90 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 83.35 & Strong Sell for SHORT-TERM with Stoploss of 87.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

4147STOCK Price

Open 61.80 Change Price %
High 62.50 1 Day 0.10 0.16
Low 61.60 1 Week -2.20 -3.43
Close 61.90 1 Month -5.30 -7.89
Volume 510262 1 Year -20.10 -24.51
52 Week High 99.70 | 52 Week Low 61.80
 
TWO Taiwan Most Active Stocks
1815 91.30 3.99%
5498 42.30 -0.24%
6127 35.95 -3.49%
4979 294.50 1.03%
8043 88.40 1.73%
1785 70.00 1.01%
6244 22.65 -2.37%
3260 223.50 9.83%
6163 55.90 -1.76%
4909 59.80 5.10%
 
TWO Taiwan Top Gainers Stocks
1784 111.00 9.90%
3499 19.45 9.89%
3260 223.50 9.83%
8299 1290.00 9.79%
8299 1290.00 9.79%
4168 27.05 9.07%
8047 60.00 8.50%
8047 60.00 8.50%
3265 118.50 7.73%
6265 22.00 7.06%
 
TWO Taiwan Top Losers Stocks
3202 3.96 -10.00%
3691 78.00 -9.09%
4130 25.90 -6.83%
4130 25.90 -6.83%
2067 10.05 -5.19%
5516 13.50 -4.93%
4406 9.70 -4.90%
5345 23.50 -4.28%
3234 49.35 -4.17%
8489 41.70 -3.81%
 
 
4147
Daily Charts
4147
Intraday Charts
Whats New @
Bazaartrend
4147
Free Analysis
 
4147 Important Levels Intraday
RESISTANCE63.63
RESISTANCE63.08
RESISTANCE62.73
RESISTANCE62.39
SUPPORT61.41
SUPPORT61.07
SUPPORT60.72
SUPPORT60.17
 
4147 Forecast December 2025
4th UP Forecast112
3rd UP Forecast95.93
2nd UP Forecast86
1st UP Forecast76.07
1st DOWN Forecast47.73
2nd DOWN Forecast37.8
3rd DOWN Forecast27.87
4th DOWN Forecast11.8
 
4147 Weekly Forecast
4th UP Forecast77.89
3rd UP Forecast72.76
2nd UP Forecast69.59
1st UP Forecast66.42
1st DOWN Forecast57.38
2nd DOWN Forecast54.21
3rd DOWN Forecast51.04
4th DOWN Forecast45.91
 
4147 Forecast2025
4th UP Forecast152.47
3rd UP Forecast123.42
2nd UP Forecast105.47
1st UP Forecast87.52
1st DOWN Forecast36.29
2nd DOWN Forecast18.33
3rd DOWN Forecast0.38
4th DOWN Forecast-28.67
 
 
4147 Other Details
Segment EQ
Market Capital 17560358912.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
4147 Address
4147
 
4147 Latest News
 
Your Comments and Response on TaiMed Biologics Inc
 
4147 Business Profile
TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases. The company develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody that is in Phase II clinical trials for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase II clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which is in Phase I clinical trials for treating HIV infections; TMB-370, a bispecific neutralizing antibody that is in Phase I clinical trials to treat HIV infections; and TMB-380, a neutralizing HIV-1 antibody. The company was founded in 2007 and is headquartered in Taipei, Taiwan. Address: No. 607, Ruiguang Road, Taipei, Taiwan, 11492
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service